NM_080425.4:c.2146G>A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_080425.4(GNAS):​c.2146G>A​(p.Gly716Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G716C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000096 ( 0 hom. )

Consequence

GNAS
NM_080425.4 missense

Scores

12
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2O:1

Conservation

PhyloP100: 3.84

Publications

7 publications found
Variant links:
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS Gene-Disease associations (from GenCC):
  • McCune-Albright syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • progressive osseous heteroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohypoparathyroidism type 1B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudohypoparathyroidism type 1C
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudopseudohypoparathyroidism
    Inheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • pseudohypoparathyroidism type 1A
    Inheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3230337).
BS2
High AC in GnomAdExome4 at 14 AD,Mitochondrial,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNASNM_080425.4 linkc.2146G>A p.Gly716Ser missense_variant Exon 3 of 13 ENST00000371100.9 NP_536350.2
GNASNM_000516.7 linkc.217G>A p.Gly73Ser missense_variant Exon 3 of 13 ENST00000371085.8 NP_000507.1
GNASNM_016592.5 linkc.*120G>A 3_prime_UTR_variant Exon 3 of 13 ENST00000371075.7 NP_057676.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNASENST00000371100.9 linkc.2146G>A p.Gly716Ser missense_variant Exon 3 of 13 5 NM_080425.4 ENSP00000360141.3
GNASENST00000371085.8 linkc.217G>A p.Gly73Ser missense_variant Exon 3 of 13 1 NM_000516.7 ENSP00000360126.3
GNASENST00000676826.2 linkc.2146G>A p.Gly716Ser missense_variant Exon 3 of 13 ENSP00000504675.2
GNASENST00000354359.12 linkc.217G>A p.Gly73Ser missense_variant Exon 3 of 13 1 ENSP00000346328.7
GNASENST00000470512.6 linkc.40G>A p.Gly14Ser missense_variant Exon 3 of 13 5 ENSP00000499552.2
GNASENST00000480232.6 linkc.40G>A p.Gly14Ser missense_variant Exon 4 of 14 5 ENSP00000499545.2
GNASENST00000663479.2 linkc.40G>A p.Gly14Ser missense_variant Exon 3 of 13 ENSP00000499353.2
GNASENST00000371075.7 linkc.*120G>A 3_prime_UTR_variant Exon 3 of 13 1 NM_016592.5 ENSP00000360115.3
GNASENST00000371102.8 linkc.2141+3261G>A intron_variant Intron 2 of 11 5 ENSP00000360143.4
GNASENST00000371095.7 linkc.212+3261G>A intron_variant Intron 2 of 11 1 ENSP00000360136.3
GNASENST00000462499.6 linkc.35+3261G>A intron_variant Intron 2 of 11 2 ENSP00000499758.2
GNASENST00000467227.6 linkc.35+3261G>A intron_variant Intron 3 of 12 3 ENSP00000499681.2
GNASENST00000478585.6 linkc.35+3261G>A intron_variant Intron 2 of 11 2 ENSP00000499762.2
GNASENST00000481039.6 linkc.35+3261G>A intron_variant Intron 2 of 11 5 ENSP00000499767.2
GNASENST00000485673.6 linkc.35+3261G>A intron_variant Intron 2 of 11 5 ENSP00000499334.2
GNASENST00000488546.6 linkc.35+3261G>A intron_variant Intron 2 of 11 5 ENSP00000499332.2
GNASENST00000492907.6 linkc.35+3261G>A intron_variant Intron 2 of 11 3 ENSP00000499443.2
GNASENST00000461152.6 linkc.*124+3261G>A intron_variant Intron 2 of 2 5 ENSP00000499274.1
GNASENST00000453292.7 linkc.*115+3261G>A intron_variant Intron 2 of 11 5 ENSP00000392000.2

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251468
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1461400
Hom.:
0
Cov.:
29
AF XY:
0.0000138
AC XY:
10
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33474
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1111568
Other (OTH)
AF:
0.00
AC:
0
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41410
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pseudohypoparathyroidism type 1B Uncertain:1
Oct 25, 2018
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Uncertain significance. The available evidence favors the benign nature of this variant, however the evidence is insufficent to prove its benign nature. The following ACMG criteria were applied in classifying this variant: PP3,BS1. -

not provided Uncertain:1
Sep 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 73 of the GNAS protein (p.Gly73Ser). This variant is present in population databases (rs587778380, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with GNAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 134473). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GNAS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Uncertain
0.091
D
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
26
DANN
Benign
0.97
DEOGEN2
Uncertain
0.60
D;.;.;D;.;T;T
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.89
D;D;D;D;D;D;D
M_CAP
Uncertain
0.098
D
MetaRNN
Benign
0.32
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Benign
-0.46
.;.;.;N;N;.;.
PhyloP100
3.8
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-1.4
N;N;.;N;N;N;.
REVEL
Uncertain
0.52
Sift
Uncertain
0.019
D;T;.;T;T;T;.
Sift4G
Uncertain
0.015
D;T;T;T;T;T;T
Polyphen
1.0
D;.;.;D;.;.;.
Vest4
0.62
MutPred
0.42
Gain of helix (P = 0.0117);.;.;.;.;.;.;
MVP
0.97
MPC
0.89
ClinPred
0.71
D
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.60
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587778380; hg19: chr20-57474000; COSMIC: COSV105846644; COSMIC: COSV105846644; API